Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Published:2021-05-29 Issue:13 Volume:8 Page:2101458
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Zhang Zhuangzhuang¹^ORCID,Cheng Lijun²,Zhang Qiongsi¹,Kong Yifan¹,He Daheng³,Li Kunyu¹,Rea Matthew⁴,Wang Jianling¹,Wang Ruixin¹,Liu Jinghui¹,Li Zhiguo¹,Yuan Chongli⁵,Liu Enze²,Fondufe‐Mittendorf Yvonne N.⁴,Li Lang²,Han Tao²,Wang Chi³,Liu Xiaoqi¹³^ORCID

Affiliation:

1. Department of Toxicology and Cancer Biology University of Kentucky Lexington KY 40536 USA

2. Department of Biomedical Informatics The Ohio State University Columbus OH 43210 USA

3. Markey Cancer Center University of Kentucky Lexington KY 40536 USA

4. Department of Molecular and Cellular Biochemistry University of Kentucky Lexington KY 40536 USA

5. School of Chemical Engineering Purdue University West Lafayette IN 47907 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202101458

Reference33 articles.

1. Cancer statistics, 2020

2. Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression

3. There are only four basic modes of cell death, although there are many ad-hoc variants adapted to different situations

4. PARP Inhibitors in Prostate Cancer—The Preclinical Rationale and Current Clinical Development

5. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis;Cell Reports;2024-07

2. A miR-361-5p/ ORC6/ PLK1 axis regulates prostate cancer progression;Experimental Cell Research;2024-07

3. TransGEM: a molecule generation model based on Transformer with gene expression data;Bioinformatics;2024-04-17

4. Mitotic Kinase Inhibitors as Therapeutic Interventions for Prostate Cancer: Evidence from In Vitro Studies;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-12

5. Polo-like kinase 1 promotes sepsis-induced myocardial dysfunction;International Immunopharmacology;2023-12